Evidence of person-to-person transmission of oseltamivir-resistant pandemic influenza A(H1N1) 2009 virus in a hematology unit.

We describe the first confirmed person-to-person transmission of oseltamivir-resistant pandemic influenza A(H1N1) 2009 virus that occurred in a hematology unit in the United Kingdom. Eleven cases of (H1N1) 2009 virus infection were identified, of which, ten were related as shown by sequence analysis of the hemagglutinin and neuraminidase genes. H275Y analysis demonstrated that 8 of 10 case patients had oseltamivir-resistant virus, with 4 of 8 case patients infected by direct transmission of resistant virus. Zanamivir should be considered as first-line therapy for influenza in patients with lymphopenic hematological conditions and uptake of influenza vaccination encouraged to further reduce the number of susceptible individuals.

[1]  Seth J. Sullivan,et al.  2009 H1N1 influenza. , 2010, Mayo Clinic proceedings.

[2]  L. Brammer,et al.  Update: influenza activity - United States, September 28, 2008--January 31, 2009. , 2009, MMWR. Morbidity and mortality weekly report.

[3]  Update: influenza activity--United States. , 1986, MMWR. Morbidity and mortality weekly report.

[4]  A. Mank,et al.  Is there still an indication for nursing patients with prolonged neutropenia in protective isolation?. An evidence-based nursing and medical study of 4 years experience for nursing patients with neutropenia without isolation. , 2003, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

[5]  Marcel Jonges,et al.  Morbidity and mortality associated with nosocomial transmission of oseltamivir-resistant influenza A(H1N1) virus. , 2009, JAMA.

[6]  Tanja Popovic,et al.  Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009. , 2009, MMWR. Morbidity and mortality weekly report.

[7]  M. Zambon,et al.  Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe. , 2008, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[8]  M. Zambon,et al.  Rapid Quantitation of Neuraminidase Inhibitor Drug Resistance in Influenza virus Quasispecies , 2008, Antiviral therapy.

[9]  D. Smee,et al.  Triple Combination of Amantadine, Ribavirin, and Oseltamivir Is Highly Active and Synergistic against Drug Resistant Influenza Virus Strains In Vitro , 2010, PloS one.

[10]  M. Jonges,et al.  Prolonged influenza virus infection during lymphocytopenia and frequent detection of drug-resistant viruses. , 2009, The Journal of infectious diseases.

[11]  J. Kanda,et al.  Insomnia and depression during protective isolation in patients with hematological disorders. , 2010, Internal medicine.

[12]  Lei Zhang,et al.  NPY Neuron-Specific Y2 Receptors Regulate Adipose Tissue and Trabecular Bone but Not Cortical Bone Homeostasis in Mice , 2010, PloS one.

[13]  J. Gray,et al.  Evaluation of four real-time PCR assays for detection of influenza A(H1N1)v viruses. , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[14]  David Posada,et al.  MODELTEST: testing the model of DNA substitution , 1998, Bioinform..